1. Home
  2. SBLX vs NXTS Comparison

SBLX vs NXTS Comparison

Compare SBLX & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SBLX

StableX Technologies Inc.

HOLD

Current Price

$3.11

Market Cap

3.7M

ML Signal

HOLD

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$4.76

Market Cap

3.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SBLX
NXTS
Founded
2017
2009
Country
United States
Israel
Employees
58
9
Industry
Telecommunications Equipment
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SBLX
NXTS
Price
$3.11
$4.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.1M
19.6K
Earning Date
05-12-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$0.55
52 Week High
$7.85
$6.21

Technical Indicators

Market Signals
Indicator
SBLX
NXTS
Relative Strength Index (RSI) 68.25 53.12
Support Level $2.83 $3.92
Resistance Level $3.11 $5.31
Average True Range (ATR) 0.43 0.62
MACD 0.06 -0.17
Stochastic Oscillator 36.89 20.98

Price Performance

Historical Comparison
SBLX
NXTS

About SBLX StableX Technologies Inc.

StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: